Eagle Asset Management Inc
- SEC CIK
- 0000790502
- Latest filing
- Nov 12, 2024
NBIX holding history
Neurocrine Biosciences Inc in every 13F filed by Eagle Asset Management Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NBIX overviewAll 13F holders of NBIXFull Q3 2024 holdings
- Shares (Q3 2024)
- 621,363
- Value
- $78.1M
- % of portfolio
- 0.4%
- Quarters held
- 8
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 621,363 | $78.1M | 0.4% | −58,671−8.6% | Reduced | Holders |
| Q2 2024 | 680,034 | $95.3M | 0.5% | −33,491−4.7% | Reduced | Holders |
| Q1 2024 | 713,525 | $100.9M | 0.5% | −14,828−2.0% | Reduced | Holders |
| Q4 2023 | 728,353 | $96.0M | 0.5% | +1,074+0.1% | Added | Holders |
| Q3 2023 | 727,279 | $81.8M | 0.5% | +489+0.1% | Added | Holders |
| Q2 2023 | 726,790 | $68.5M | 0.4% | +448,619+161.3% | Added | Holders |
| Q1 2023 | 278,171 | $28.2M | 0.2% | −314−0.1% | Reduced | Holders |
| Q4 2022 | 278,485 | $33.4M | 0.2% | +278,485 | New | Holders |